ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 670

$1.16M Total Retail Price of All Prescriptions

Rank: 17 out of 670

464 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 502 419 1 4
OMEPRAZOLE 463 408 2 5
HYDROCODONE-ACETAMINOPHEN 453 361 S3 3 1
WARFARIN SODIUM 442 413 4 13
LEVOTHYROXINE SODIUM 362 330 5 2
AMLODIPINE BESYLATE 342 318 6 7
HYDROCHLOROTHIAZIDE 327 291 7 10
POTASSIUM CHLORIDE 307 278 8 16
ATENOLOL 285 265 9 17
FUROSEMIDE 279 240 10 6
TRAMADOL HCL 273 226 11 21
LISINOPRIL 258 201 12 3
ZOLPIDEM TARTRATE 253 226 13 23
NEXIUM 239 196 14 14
CRESTOR 238 207 15 18
LANTUS 236 195 16 58
GABAPENTIN 228 206 17 11
METOPROLOL SUCCINATE 207 182 18 12
METOPROLOL TARTRATE 195 166 19 9
LOSARTAN POTASSIUM 186 171 20 26
CITALOPRAM HBR 179 166 21 20
ISOSORBIDE MONONITRATE ER 174 160 22 45
LEVOFLOXACIN 169 145 23 88
CEFDINIR 150 126 24 154
ALENDRONATE SODIUM 144 137 25 43
SERTRALINE HCL 144 133 25 22
CLOPIDOGREL 142 133 27 24
TAMSULOSIN HCL 140 128 28 30
DIGOXIN 136 112 29 46
NAMENDA 128 128 30 54
TORSEMIDE 123 112 31 100
METFORMIN HCL 119 104 32 8
GLYBURIDE 117 117 R 33 85
BENAZEPRIL HCL 115 102 34 90
PANTOPRAZOLE SODIUM 110 79 35 41
ADVAIR DISKUS 109 98 36 42
FLUTICASONE PROPIONATE 108 102 37 37
DONEPEZIL HCL 108 108 37 31
ATORVASTATIN CALCIUM 103 82 39 15
PLAVIX 100 93 40 34
DIVALPROEX SODIUM 100 87 40 95
JANUVIA 95 75 42 53
CARBIDOPA-LEVODOPA 94 77 43 101
EXELON 92 92 44 128
METFORMIN HCL ER 89 67 45 63
CYMBALTA 89 77 45 36
INSULIN SYRINGE 88 70 47 92
DEXILANT 87 63 48 70
METHYLPREDNISOLONE 82 62 49 120
SINGULAIR 80 66 50 56
ETODOLAC 79 35 51 174
NYSTATIN 75 69 52 139
RANITIDINE HCL 72 49 53 25
PAROXETINE HCL 69 69 54 52
FELODIPINE ER 69 55 54 144
ALLOPURINOL 69 57 54 38
PRAMIPEXOLE DIHYDROCHLORIDE 69 48 54 198
ABILIFY 68 43 58 200
LYRICA 67 43 59 65
LACTULOSE 67 60 59 107
DIOVAN 66 53 61 48
MECLIZINE HCL 66 62 61 114
EVISTA 66 66 61 158
THEOPHYLLINE ANHYDROUS 65 60 64 181
ROPINIROLE HCL 65 52 64 75
SPIRIVA 65 59 64 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 50 67 27
RISPERIDONE 62 46 68 80
LANSOPRAZOLE 62 57 68 86
ALPRAZOLAM 62 52 68 138
QUETIAPINE FUMARATE 61 61 71 84
FINASTERIDE 60 47 72 118
CELEBREX 57 54 73 89
CARVEDILOL 57 57 73 29
NOVOLOG 55 48 75 151
MIRTAZAPINE 53 53 76 59
ESCITALOPRAM OXALATE 53 45 76 78
AVODART 53 48 76 208
SOTALOL 52 49 79 250
PREDNISONE 52 45 79 40
METOCLOPRAMIDE HCL 51 35 81 117
GLIPIZIDE 51 47 81 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 42 81 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.